期刊文献+

2015—2017年天津市津南区咸水沽医院解热镇痛抗炎药品的使用情况分析 被引量:3

Analysis on usage of antipyretic, analgesic and anti-inflammatory drugs in Jinnan Xianshuigu Hospital of Tianjin City from 2015 to 2017
原文传递
导出
摘要 目的调查分析2015—2017年天津市津南区咸水沽医院解热镇痛抗炎药品的应用情况及趋势,为科学管理和合理应用提供参考。方法采用数据回顾性方法,对天津市津南区咸水沽医院解热镇痛抗炎药品的用药金额、用药数量及构成比、限定日计量(DDD)值、用药频度(DDDs)及日均费用(DDC)等数据进行统计与分析。结果共有28种解热镇痛抗炎药,涵盖口服、注射、外用3种剂型。口服剂型解热镇痛抗炎药的销售金额逐年上升,注射剂型解热镇痛抗炎药的销售金额逐年下降。洛索洛芬钠分散片的销售金额及构成比稳居首位。2015年注射用氯诺昔康的销售金额居第2位,但2016、2017年,注射用精氨酸阿司匹林跃居第2位。氨咖黄敏口服溶液的DDDs稳居首位。牛痘疫苗接种家兔炎症皮肤提取物片的DDC排名第1位,2017年加巴喷丁胶囊的DDC排名跃居第1位。结论天津市津南区咸水沽医院解热镇痛抗炎药品的管理比较规范,药物使用大致合理。 Objective To investigate the status and trends of antipyretic, analgesic, and anti-inflammatory drugs in Jinnan Xianshuigu Hospital of Tianjin City from 2015 to 2017, in order to provide reference for the scientific management and rational application. Methods Data used retrospectively to determine the total amount of antipyretic and anti-inflammatory drugs used in our hospital, Consumption sum, total amount and composition ratio, definite daily dosage(DDD), defined daily doses(DDDs), and defined daily cost(DDC) were analyzed statistically by a retrospective analysis method. Results There were 28 antipyretic, analgesic, and anti-inflammatory drugs, covering three dosage forms: oral, injection, and topical. Consumption sum of antipyretic, analgesic, and anti-inflammatory drugs in oral dosage forms increased year by year, and the amount of antipyretic, analgesic, and anti-inflammatory drugs in injection dosage forms decreased year by year. The sales amount and composition ratio of Loxoprofen Sodium Dispersible Tablets ranked the first. Lornoxicam for injection was ranked the second in 2015, but Arginine Acetylsalicylate for injection ranked the second in 2016 and 2017. DDDs of Anka Huangmin Oral Solution remained the top place. DDC of Extract Tablets from Inflammatory Cutaneous Tissues of the Rabbit Inoculated with Vaccina Virus was ranked the first. In 2017, DDC ranking of Gabapentin Capsules ranked the first. Conclusion The management of antipyretic, analgesic and anti-inflammatory drugs in Jinnan Xianshuigu Hospital of Tianjin City is relatively standardized, and the use of drugs is generally reasonable.
作者 魏然 WEI Ran(Department of pharmacy,Jinnan Xianshuigu Hospital of Tianjin City,Tianjin 300350,China)
出处 《现代药物与临床》 CAS 2018年第11期3043-3048,共6页 Drugs & Clinic
关键词 解热镇痛抗炎药品 销售金额 限定日剂量 用药频度 日均费用 antipyretic analgesic and anti-inflammatory drugs consumption sum definite daily dosage defined daily doses defineddaily cost
  • 相关文献

二级参考文献38

  • 1高益民,王忠山.对痰热清注射液临床药学初步评价[J].首都医药,2004,11(12):44-46. 被引量:205
  • 2王先爱,沈焕云.癌症患者疼痛和生活质量的调查分析[J].临床护理杂志,2005,4(3):3-4. 被引量:7
  • 3孙丽华,杨桐伟.咪达唑仑的临床应用进展[J].吉林医学,2006,27(12):1469-1470. 被引量:13
  • 4[1]Pruss T P,Stroissing H,Radhofer W S,et al.Overview of the pharmacological properties,pharmacokinetics and animal safety assessment of lornoxicam[J].Postgrad.Med.J,1990,66:Suppl.4,18
  • 5[2]Urano H,Itoga H,Fukushima K,et al.Disposition of lornoxicam (2)-tissue distribution, foeto-placental transfer and tranfer into milk after single administration to rats[J].Kiso To Rinsho,1997,31(4):21
  • 6[3]Hitzenberger G,Radhofer Welte S,Takacs F,et al.Pharmacokinetics of lornoxicam in man[J].Postgrad.Med.J,1990,66:Suppl.4,22
  • 7[4]Turner P,Johnston-A.Clinical pharmacokinetic studies with lornoxicam[J].Postgrad.Med.J,1990,66:Suppl.4,28
  • 8[5]Atzpodien E,Mehdi N,Clarke D,et al.Subacute and chronic oral toxicity of lornoxicam in cynomolgus monkeys[J].Food-Chem-Toxocol,1997,35:ISS 5,465
  • 9[6]Pohlmeyer E G,Mehdi N,Clarke D,et al.Evaluation of chronic oral toxicity and carcinogenic potential of lornoxicam in rat[J].Food-Chem-Toxocol,1997,35:ISS 9,909
  • 10[7]Rosenow DE,van Krieken F,Stolke D,et al.Intravenous administration of lornoxicam,a new NSAID,and pethidine for postoperation pain[J].Clin Drug Invest,1996,11(1):11

共引文献83

同被引文献23

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部